For purposes of this division, the following definitions apply:

(a) “Donor” means an individual who donates unused prescription drugs to a participating practitioner for the purpose of redistribution to established patients of that practitioner.

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.

(b) “Ineligible drugs” means drugs that are not able to be accepted for redistribution as part of the program established pursuant to this division. “Ineligible drugs” include all controlled substances, including all opioids, all compounded medications, injectable medications, drugs that have an approved United States Food and Drug Administration Risk Evaluation and Mitigation Strategy (REMS) requirement, and all growth factor medications.

(c) “Participating practitioner” means a person who is licensed to practice medicine by the Medical Board of California and is board certified in medical oncology or hematology and is registered with a surplus medication collection and distribution intermediary.

(d) “Recipient” means an individual who voluntarily receives donated prescription medications.

(e) “Surplus medication collection and distribution intermediary” means an entity licensed pursuant to § 4169.5 of the Business and Professions Code as a surplus medication collection and distribution intermediary, as described in Section 150208.

(f) “Unused cancer medication” or “medication” means a medication or drug, including a “dangerous drug” as defined in § 4022 of the Business and Professions Code or a “drug” as defined in § 4025 of the Business and Professions Code, that is prescribed as part of a cancer treatment plan and is in its original container or packaging.

(Added by Stats. 2021, Ch. 541, Sec. 2. (SB 310) Effective January 1, 2022. Repealed as of January 1, 2027, pursuant to Section 150404.)